KV's new directors oust interim CEO; Chinese FDA deputy fired under suspicion;

@FiercePharma: Has pharma outgrown the scientist CEO? Report | Follow @FiercePharma

> Within hours of being elected, KV Pharmaceutical's new board members ousted interim President and Chief Executive David Van Vliet and installed Gregory Divis in his place. Release | Report

> A deputy chief of China's food and drug regulator has been sacked and is being investigated for disciplinary violations, flagging another possible corruption scandal for the watchdog. Report

> To check the import of unauthorised active pharmaceutical ingredients from China, India may send drug inspectors to examine certain bulk drug production units there. Report

> Dr. Reddy's Laboratories saw its Mumbai shares fall the most in more than four months after a court in the U.S. blocked sales of its version of allergy medication Allegra. Report

> Abbott Vascular, a division of Abbott Laboratories, laid off 120 workers from its California operations. Report

> Gilead Sciences (GILD.O) said it may take legal action against Lupin (LUPN.BO) after the Indian firm applied for FDA approval to manufacture a generic version of its angina drug, Ranexa. Report

> Cadila Pharmaceuticals and Novavax have completed construction of their joint venture vaccine manufacturing plant in Dholka, India. Report

Biotech News

 @FierceBiotech: Big Pharma coalition will pool data on failed Alzheimer's drugs. Report | Follow @FierceBiotech

 @JohnCFierce: Ain't it cool science: Plastic antibodies used to "cure "mice of bee venom. Report | Follow @JohnCFierce

> Analysis: Fewer approvals may prove R&D is getting tougher. Article

> BioScale banks $25M to back protein analytics tech. Report

> Agile raises $45M for contraceptive patch trials. News

> HGS's hep C drug Zalbin hits an FDA hurdle. Item

Biotech IT News

> Merck's cancer network pushes collaboration. Interview

> Nextrials, Formedix integrate platforms. Report

> Perceptive, XClinical debut study-design automation tools. Article

> Big pharmas to share Alzheimer's drug data. Article

And Finally... A plan by Navistar International to drop some retirees' prescription benefits has run into union opposition, turning into a skirmish that is likely to be replayed at other U.S. companies amid federal health-care changes. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.